Home > Products and Services > Reporter Assays Home > SureENTRY™ Transduction Reagent
SureENTRY™ Transduction Reagent
The SureENTRY™ Transduction Reagent enhances lentiviral/retroviral
transductions 10-fold to 1000-fold in most mammalian cell types, with minimal
toxicity. The success of an experiment involving lentiviral delivery technology
is often dependent upon the efficiency with which the genetic payload is
delivered into the target cells. Including SureENTRY Transduction Reagent in
your transduction protocol dramatically improves the efficiency of lentiviral/retroviral
delivery. The SureENTRY Transduction Reagent is a valuable accessory product for
any experiment using Cignal Lenti Reporters.
Product Listing
| Product Name |
Cat # |
Unit |
SureENTRY Transduction Reagent
|
SA-02 |
0.5 ml (enough for 12,500
transductions or 130 96-well plates) |
Why Use SureENTRY Transduction Reagent?
- High Efficiency Transduction
SureENTRY Transduction Reagent has been shown to enhance lentiviral
transduction 10-fold to 1000-fold, depending upon the target cell
- Sterile Cell Culture Grade Reagent
Ready to use aqueous solution simplifies your lentiviral transduction
protocols
- Optimized Formulation
No need to screen numerous transduction reagent formulations
HOW IT WORKS
APPLICATIONS DATA
- Study cell signaling in Primary Cells, Stem Cells, and Difficult to Transfect Cell Lines
Cignal Lenti NFAT reporter determines PKA/Ca 2+ pathway activity in human
primary cells (Normal Human Pulmonary Artery Smooth Muscle Cells; PASMC):
Cignal Lenti NFAT reporter (luc) [4X105 TU] and Cignal Lenti Renilla
control (luc) [1X105 TU] co-transduced around 10,000 PASMC cells in the presence of 8 µg/ml SureENTRY Transduction Reagent (24 hours
before transduction 5,000 cells were plated per well of 96-well plate). After 48
hours of transduction, medium was changed to assay medium (Opti-MEM + 0.5% FBS +
0.1mM NEAA + 1mM Sodium pyruvate + 100 U/ml penicillin + 100 µg/ml
streptomycin). After 54 hours of transduction, cells were treated with 10 ng/ml
PMA and 0.5 µM ionomycin for 18 hours. Dual-luciferase assay was performed, and
promoter activity values are expressed as arbitrary units using a Renilla
reporter for internal normalization. Experiments were done in triplicates, and
the standard deviation is indicated.
Cignal Lenti NFkB reporter measures NFkB pathway activity in thymocytic
cells (D1; Murine T-Cell Leukemia Cells): Cignal Lenti NFΚB reporter (luc)
[2.5X105 TU] transduced around 10,000 D1 cells, an IL-7-dependent
murine thymocyte cell, in the presence of 8 µg/ml SureENTRY Transduction Reagent (24 hours before transduction 5,000 cells were plated per
well of 96-well plate). After 48 hours of transduction, cells were treated with
20 ng/ml of recombinant mouse tumor necrosis factor alpha (hTNFα) protein for 18
hours. Luciferase assay was performed, and promoter activity values are
expressed as arbitrary units. Experiments were done in triplicates, and the
standard deviation is indicated.
|
Brochures
Cignal Lenti Reporter
|